Hao Huang is a dedicated biotech investor and business developer currently at AstraZeneca, where they focus on equity investment and sourcing for global R&D in the China biopharmaceutical industry. Hao earned a Ph.D. and M.S. in Chemistry from the University of Chicago, where they also worked as a Graduate Research Assistant. Their professional journey includes key roles at Roche pRED and Novartis Institutes for BioMedical Research, as well as significant leadership positions at Jiangsu Hengrui Medicine Co., Ltd. and Pivotal Bioventure China, contributing to advancements in large-molecule drug discovery and the incubation of startup biotech companies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices